Certain Common Stock of Tarsus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 31-MAY-2024. These Common Stock will be under lockup for 91 days starting from 1-MAR-2024 to 31-MAY-2024.

Details:
The company, it's executive officers and directors and certain of stockholders have agreed that, subject to certain exceptions, during the period ending 90 days after the date of this prospectus supplement, will not offer, sell, dispose of or hedge any shares of common stock or securities convertible into or exchangeable for shares of common stock, subject to specified limited exceptions.